SAT0196 Repeated rituximab infusions for the therapy of rheumatoid arthritis is not associated with increased rates of serious infections
Sign Up to like & getrecommendations! Published in 2017 at "Annals of the Rheumatic Diseases"
DOI: 10.1136/annrheumdis-2017-eular.1752
Abstract: Background Extended observations in clinical trials have not demonstrated an increased risk of serious infection events (SIE) in patients with rheumatoid arthritis (RA) treated with rituximab.1 However, continuous surveillance using large-scale observational data is of… read more here.
Keywords: corrona; infusion; employee; corrona llc ... See more keywords
FRI0188 Effectiveness of adalimumab combination therapy with methotrexate and non-methotrexate csdmards: results from the corrona rheumatoid arthritis registry
Sign Up to like & getrecommendations! Published in 2017 at "Annals of the Rheumatic Diseases"
DOI: 10.1136/annrheumdis-2017-eular.1924
Abstract: Background Combination therapy of methotrexate (MTX) with biologics results in superior outcomes vs. monotherapy. However, little is known on the effectiveness of adalimumab (ADA) combination therapy with non-MTX conventional synthetic disease modifying anti-rheumatic drugs (csDMARD).… read more here.
Keywords: combination; abbvie; employee; corrona llc ... See more keywords